1 of 54

Bayer Group Consolidated Income Statements

		[Table 4.1]
	Note	2008	2009
		€ million	€ million
Net sales	[7]	32,918	31,168
Cost of goods sold		(16,456)	(15,135)
Gross profit		16,462	16,033

Selling expenses	[8]	(8,105)	(7,923)
Research and development expenses	[9]	(2,653)	(2,746)
General administration expenses		(1,649)	(1,623)
Other operating income	[10]	907	922
Other operating expenses	[11]	(1,418)	(1,657)
Operating result [EBIT]		3,544	3,006

Equity-method loss	[13.1]	(62)	(48)
Non-operating income		589	789
Non-operating expenses		(1,715)	(1,877)
Non-operating result	[13]	(1,188)	(1,136)

Income before income taxes		2,356	1,870

Income taxes	[14]	(636)	(511)

Income from continuing operations after taxes		1,720	1,359

Income from discontinued operations after taxes	[6.3]	4	-

Income after taxes		1,724	1,359
of which attributable to non-controlling interest	[15]	5	-
of which attributable to Bayer AG stockholders (net income)		1,719	1,359

Earnings per share (€)

From continuing operations	[16]
Basic*		2.22	1.70
Diluted*		2.22	1.70

From discontinued operations	[16]
Basic*		-	-
Diluted*		-	-

From continuing and discontinued operations	[16]
Basic*		2.22	1.70
Diluted*		2.22	1.70
* The ordinary shares that resulted from conversion of the mandatory convertible bond were treated as already issued shares following the issuance of the bond.